271 related articles for article (PubMed ID: 32529266)
1. A systematic review on the genotoxic effect of serotonin and norepinephrine reuptake inhibitors (SNRIs) antidepressants.
Ahmadimanesh M; Balarastaghi S; Rashedinia M; Yazdian-Robati R
Psychopharmacology (Berl); 2020 Jul; 237(7):1909-1915. PubMed ID: 32529266
[TBL] [Abstract][Full Text] [Related]
2. Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: A systematic review and meta-analysis.
Khanassov V; Hu J; Reeves D; van Marwijk H
Int J Geriatr Psychiatry; 2018 Dec; 33(12):1688-1708. PubMed ID: 30247774
[TBL] [Abstract][Full Text] [Related]
3. [TREATMENT OF SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITORS (SSRIS AND SNRIS) DURING PREGNANCY AND LACTATION].
Rozner L; Aisenberg Romano G; Klieger C; Bloch M
Harefuah; 2023 Feb; 162(2):86-91. PubMed ID: 36916077
[TBL] [Abstract][Full Text] [Related]
4. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis.
Locher C; Koechlin H; Zion SR; Werner C; Pine DS; Kirsch I; Kessler RC; Kossowsky J
JAMA Psychiatry; 2017 Oct; 74(10):1011-1020. PubMed ID: 28854296
[TBL] [Abstract][Full Text] [Related]
6. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
[TBL] [Abstract][Full Text] [Related]
7. A Systematic Review on the Genotoxic Effects of Selective Serotonin Reuptake Inhibitors.
Ahmadimanesh M; Abbaszadegan MR; Hedayati N; Yazdian-Robati R; Jamialahmadi T; Sahebkar A
Adv Exp Med Biol; 2021; 1286():115-124. PubMed ID: 33725349
[TBL] [Abstract][Full Text] [Related]
8. Modern bioanalytical methods for the rapid detection of antidepressants: SNRIs and SSRIs in human biological samples.
Samanidou V; Kourti P
Bioanalysis; 2009 May; 1(2):451-88. PubMed ID: 21083177
[TBL] [Abstract][Full Text] [Related]
9. Serotonin-norepinephrine reuptake inhibitor antidepressants and the risk of falls in older people: case-control and case-series analysis of a large UK primary care database.
Gribbin J; Hubbard R; Gladman J; Smith C; Lewis S
Drugs Aging; 2011 Nov; 28(11):895-902. PubMed ID: 22054230
[TBL] [Abstract][Full Text] [Related]
10. Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults.
Sobieraj DM; Martinez BK; Hernandez AV; Coleman CI; Ross JS; Berg KM; Steffens DC; Baker WL
J Am Geriatr Soc; 2019 Aug; 67(8):1571-1581. PubMed ID: 31140587
[TBL] [Abstract][Full Text] [Related]
11. Serotonin-norepinephrine reuptake inhibitors and the influence of binding affinity (Ki) on analgesia.
Raouf M; Glogowski AJ; Bettinger JJ; Fudin J
J Clin Pharm Ther; 2017 Aug; 42(4):513-517. PubMed ID: 28503727
[TBL] [Abstract][Full Text] [Related]
12. Role of serotonin and norepinephrine transporters in antidepressant-induced arterial hypertension: a pharmacoepidemiological-pharmacodynamic study.
Montastruc JL; Rousseau V; de Canecaude C; Roussin A; Montastruc F
Eur J Clin Pharmacol; 2020 Sep; 76(9):1321-1327. PubMed ID: 32483650
[TBL] [Abstract][Full Text] [Related]
13. [Discontinuation of SSRIs and SNRIs].
Ruhe HG; Horikx A; van Avendonk MJP; Groeneweg BF; Mulder H; Woutersen-Koch H
Ned Tijdschr Geneeskd; 2020 Feb; 164():. PubMed ID: 32186829
[TBL] [Abstract][Full Text] [Related]
14. [Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
Ishigooka J
Nihon Rinsho; 2001 Aug; 59(8):1523-9. PubMed ID: 11519152
[TBL] [Abstract][Full Text] [Related]
15. Use of selective serotonin and norepinephrine reuptake inhibitors (SNRIs) in the treatment of autism spectrum disorder (ASD), comorbid psychiatric disorders and ASD-associated symptoms: a clinical review.
Nanjappa MS; Voyiaziakis E; Pradhan B; Mannekote Thippaiah S
CNS Spectr; 2022 Jun; 27(3):290-297. PubMed ID: 33280640
[TBL] [Abstract][Full Text] [Related]
16. The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials.
Azizi M; Khani S; Kamali M; Elyasi F
Iran J Med Sci; 2022 May; 47(3):173-193. PubMed ID: 35634530
[TBL] [Abstract][Full Text] [Related]
17. Serotonin norepinephrine reuptake inhibitors in managing neuropathic pain following spinal and non-spinal surgery: A systematic review and meta-analysis of randomized controlled trials.
de Liyis BG; Sutedja JC; Tjandra DC; Widha Putri NLPS; Gunawan MFB; Karuniamaya CP; Barus JFA; Pinzon RT; Widyadharma IPE
Clin Neurol Neurosurg; 2024 Apr; 239():108223. PubMed ID: 38484604
[TBL] [Abstract][Full Text] [Related]
18. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
Humble M
Acta Psychiatr Scand Suppl; 2000; 402():28-36. PubMed ID: 10901156
[TBL] [Abstract][Full Text] [Related]
19. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
[TBL] [Abstract][Full Text] [Related]
20. SNRIs achieve faster antidepressant effects than SSRIs by elevating the concentrations of dopamine in the forebrain.
Li J; Lu C; Gao Z; Feng Y; Luo H; Lu T; Sun X; Hu J; Luo Y
Neuropharmacology; 2020 Oct; 177():108237. PubMed ID: 32710978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
